Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  0.39 09:32 AM EST  
    Day High 0.41 11:30 AM EST
    Range 0.02  
    Volume 34,364  
    30-Day Avg Vol 681,000
    Difference -94.95%  
    Market Cap 14.41 M  
    Mkt Cap Chg 0  
    Shares Out 35.15 M  
    % Shrs Traded 0.10%  
    1yr EPS Est -0.04  
    52-Wk Low 0.21
    52-Wk High 1.15
    Range 0.94  
    Prev Close 0.41 11/25/09  
    Today's Open 0.40  
    Change -2.44%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date
    Div Date
    Short Interest 201,774.00

    Performance Details

    Revenue (LFY) 4.81 M  
    Earnings (LFY) -42.31 M  
    Earnings (MRQ) 2.66 M  
    Next Earn Est -0.01  
    Next Earnings 03/29/2010
    EPS (TTM) -0.34  
    1yr EPS Growth 94.29%  
    P/E Ratio (TTM)  
    P/E Ratio (Fwd) -10.00  
    PEG Ratio  
    Return on Equity -219.30  
    Beta 1.01  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: MBRX

    Blogs are not currently available for mbrx.

    View all blogs at BloggingStocks.

  • Related Information: MBRX

    Company Overview: MBRX

    Metabasis Therapeutics knows the pathways in the liver aren't lined with roses. The development-stage biotechnology company develops small-molecule drugs to combat cancer and metabolic and other diseases ... View Full Description

    Earnings Analysis: MBRX

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter -0.01 N/A
    Last Quarter -0.12 6/30/09 0.09 6/30/09 0.21
    Beat
    2 Quarters Ago -0.24 3/31/09 -0.23 3/31/09 0.01
    Beat

    Financials: MBRX

      Quarterly - 09/30/2009 Annual - 2008
    Total Revenue 4.88 M 4.81 M
    Gross Profit -4.94 M -31.55 M
    Operating Income 2.66 M -42.30 M
    Net Income 2.66 M -42.31 M